Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American perspective …
A growing number of patients undergoing percutaneous coronary intervention (PCI) with
stent implantation also have atrial fibrillation. This poses challenges for their optimal …
stent implantation also have atrial fibrillation. This poses challenges for their optimal …
Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American perspective …
The optimal antithrombotic treatment regimen for patients with atrial fibrillation undergoing
percutaneous coronary intervention with stent implantation represents a challenge in clinical …
percutaneous coronary intervention with stent implantation represents a challenge in clinical …
Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a North American perspective—2016 update
The optimal antithrombotic treatment regimen for patients with atrial fibrillation undergoing
percutaneous coronary intervention with stent implantation is an emerging clinical problem …
percutaneous coronary intervention with stent implantation is an emerging clinical problem …
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review
D Capodanno, K Huber, R Mehran, GYH Lip… - Journal of the American …, 2019 - jacc.org
Most patients with atrial fibrillation (AF) and risk factors for stroke require oral anticoagulation
(OAC) to decrease the risk of stroke or systemic embolism. This is now best achieved with …
(OAC) to decrease the risk of stroke or systemic embolism. This is now best achieved with …
Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation
A Rubboli, JL Halperin, KE Juhani Airaksinen… - Annals of …, 2008 - Taylor & Francis
Dual antiplatelet treatment with aspirin and clopidogrel is recommended after coronary
stenting (PCI-S). There is scant evidence defining optimal post-PCI-S antithrombotic therapy …
stenting (PCI-S). There is scant evidence defining optimal post-PCI-S antithrombotic therapy …
Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention
M Lamberts, GH Gislason, JB Olesen… - Journal of the American …, 2013 - jacc.org
Objectives: The purpose of this study was to investigate the risk of thrombosis and bleeding
according to multiple antithrombotic treatment regimens in atrial fibrillation (AF) patients after …
according to multiple antithrombotic treatment regimens in atrial fibrillation (AF) patients after …
Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic …
G Gargiulo, A Goette, J Tijssen, L Eckardt… - European heart …, 2019 - academic.oup.com
Aims To investigate the safety and efficacy of double vs. triple antithrombotic therapy (DAT
vs. TAT) in patients with atrial fibrillation (AF) and acute coronary syndrome or who …
vs. TAT) in patients with atrial fibrillation (AF) and acute coronary syndrome or who …
An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment …
Background Guidelines recommendations regarding anticoagulant therapy after
percutaneous coronary intervention (PCI) among patients with atrial fibrillation (AF) rely on …
percutaneous coronary intervention (PCI) among patients with atrial fibrillation (AF) rely on …
Safety and efficacy of antithrombotic strategies in patients with atrial fibrillation undergoing percutaneous coronary intervention: a network meta-analysis of …
Importance The antithrombotic treatment of patients with atrial fibrillation (AF) and coronary
artery disease, in particular with acute coronary syndrome (ACS) and/or percutaneous …
artery disease, in particular with acute coronary syndrome (ACS) and/or percutaneous …
Open-label randomized trial comparing oral anticoagulation with and without single antiplatelet therapy in patients with atrial fibrillation and stable coronary artery …
Y Matsumura-Nakano, S Shizuta, A Komasa… - Circulation, 2019 - Am Heart Assoc
Background: Despite recommendations in the guidelines and consensus documents, there
has been no randomized controlled trial evaluating oral anticoagulation (OAC) alone without …
has been no randomized controlled trial evaluating oral anticoagulation (OAC) alone without …
相关搜索
- atrial fibrillation antithrombotic therapy
- oral anticoagulation antithrombotic therapy
- atrial fibrillation oral anticoagulation
- atrial fibrillation meta analysis
- oral anticoagulation coronary intervention
- fibrillation patients coronary intervention
- consensus document antithrombotic therapy
- atrial fibrillation consensus document
- oral anticoagulation consensus document
- oral anticoagulation artery stenting
- artery stenting antithrombotic therapy
- atrial fibrillation artery stenting
- myocardial infarction coronary intervention
- oral anticoagulation myocardial infarction
- fibrillation patients myocardial infarction
- atrial fibrillation safety and efficacy